Signal2026-07-31
ClinicalTrials.gov

[PHASE2] A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

Part of

Ferroptosis Targeted Lung Cancer Therapies

Open primary sourceSee the whole picture